Association between nirmatrelvir plus ritonavir and the outcomes of non-hospitalized obese patients with COVID-19
Objective To investigate the association between nirmatrelvir plus ritonavir (NMV-r) and the
outcomes of non-hospitalized obese patients with coronavirus disease 2019 (COVID-19) …
outcomes of non-hospitalized obese patients with coronavirus disease 2019 (COVID-19) …
Denosumab, for osteoporosis, reduces the incidence of type 2 diabetes, risk of foot ulceration and all‐cause mortality in adults, compared with bisphosphonates: An …
AE Henney, DR Riley, B O'Connor… - Diabetes, Obesity …, 2024 - Wiley Online Library
Aim To evaluate the impact of denosumab on (i) the incidence of type 2 diabetes (T2D), and
(ii) long‐term health outcomes (microvascular [neuropathy, retinopathy, nephropathy] and …
(ii) long‐term health outcomes (microvascular [neuropathy, retinopathy, nephropathy] and …
Effectiveness of recently-approved oral antiviral medications on the outcome of patients with mild-to-moderate COVID-19 and pre–existing chronic obstructive …
Objectives This study assessed the effectiveness of the oral antiviral agents nirmatrelvir–
ritonavir (NMV-r) and molnupiravir (MOV) for treating mild-to-moderate coronavirus disease …
ritonavir (NMV-r) and molnupiravir (MOV) for treating mild-to-moderate coronavirus disease …
Risk of diabetic retinopathy and diabetic macular oedema with sodium–glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists in type 2 …
A Eleftheriadou, D Riley, SS Zhao, P Austin… - Diabetologia, 2024 - Springer
Aims/hypothesis A protective role of sodium–glucose cotransporter 2 inhibitors (SGLT2is)
and glucagon-like peptide 1 receptor agonists (GLP1-ra) in the development of diabetic …
and glucagon-like peptide 1 receptor agonists (GLP1-ra) in the development of diabetic …
Understanding enterprise data warehouses to support clinical and translational research: impact, sustainability, demand management, and accessibility
TR Campion Jr, CK Craven, DA Dorr… - Journal of the …, 2024 - academic.oup.com
Abstract Objectives Healthcare organizations, including Clinical and Translational Science
Awards (CTSA) hubs funded by the National Institutes of Health, seek to enable secondary …
Awards (CTSA) hubs funded by the National Institutes of Health, seek to enable secondary …
Comparative Outcomes of Empagliflozin to Dapagliflozin in Patients With Heart Failure
KL Modzelewski, A Pipilas, NA Bosch - JAMA Network Open, 2024 - jamanetwork.com
Importance Sodium-glucose cotransporter-2 (SGLT2) inhibitors have been shown to have
benefits when used in patients with heart failure. The comparative outcomes of SGLT2 …
benefits when used in patients with heart failure. The comparative outcomes of SGLT2 …
Morbidity and mortality risks associated with valproate withdrawal in young men and women with epilepsy
Valproate is the most effective treatment for idiopathic generalised epilepsy. Current
guidance precludes its use in women of childbearing potential, unless other treatments are …
guidance precludes its use in women of childbearing potential, unless other treatments are …
Risk of cytomegalovirus diseases among coronavirus disease survivors: A retrospective cohort study
This study was aimed at investigating the risk of cytomegalovirus (CMV) disease among
coronavirus disease 2019 (COVID‐19) survivors. In this retrospective cohort study, we used …
coronavirus disease 2019 (COVID‐19) survivors. In this retrospective cohort study, we used …
Glucagon-Like Peptide 1 Receptor Agonists and 13 Obesity-Associated Cancers in Patients With Type 2 Diabetes
L Wang, R Xu, DC Kaelber, NA Berger - JAMA Network Open, 2024 - jamanetwork.com
Importance Thirteen human malignant neoplasms have been identified as obesity-
associated cancers (OACs), ie, the presence of excess body fat is associated with increased …
associated cancers (OACs), ie, the presence of excess body fat is associated with increased …
Prevalence of neuromyelitis optica spectrum disorder in the United States
FBS Briggs, J Shaia - Multiple Sclerosis Journal, 2024 - journals.sagepub.com
Background: Neuromyelitis optic spectrum disorder (NMOSD) is a rare demyelinating,
autoimmune disease and the burden in United States is not well characterized. Objective …
autoimmune disease and the burden in United States is not well characterized. Objective …